Clinical Trial: Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG
Study Status: Completed
Recruit Status: RECRUITING
Condition: High-Grade Glioma
Study Type: INTERVENTIONAL
Official Title: A Phase 1b, Open-Label, Study of a Novel Targeted Radiotherapy in Children, Adolescents and Young Adults With Inoperable Relapsed or Refractory High-Grade Glioma
Brief Summary:
The purpose of this dose finding study is to evaluate the safety and efficacy of 2 different dose levels of CLR 131 in children, adolescents and young adults with relapsed or refractory high-grade glioma (HGG).
Read more